INVEGA TRINZA® Delivers Sustained Plasma Concentrations for up to 3 Months1,2
Due to the difference in median pharmacokinetic profiles between the 2 products (INVEGA TRINZA® and INVEGA SUSTENNA® [paliperidone palmitate]), caution should be exercised when making a direct comparison of their pharmacokinetic properties.2
Correlation to clinical effect has not been established.
References: 1. INVEGA TRINZA® [prescribing information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; February 2017. 2. Data on file. Janssen Pharmaceuticals, Inc., Titusville, NJ.
Content area 1.2